Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2006 2
2007 3
2008 2
2009 2
2010 1
2011 2
2012 9
2013 6
2014 5
2015 1
2016 1
2017 2
2018 2
2019 8
2020 12
2021 7
2022 9
2023 17
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landewé R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H; COAST-V study group. van der Heijde D, et al. Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22. Lancet. 2018. PMID: 30360964 Clinical Trial.
Korean treatment recommendations for patients with axial spondyloarthritis.
Seo MR, Yeo J, Park JW, Lee YA, Lee JH, Kang EH, Ji SM, Kwon SR, Kim SK, Kim TJ, Kim TH, Kim HW, Park MC, Shin K, Lee SH, Lee EY, Cha HS, Shim SC, Yoon Y, Lee SH, Lim JH, Baek HJ; Korean Society of Spondyloarthritis Research. Seo MR, et al. Among authors: park mc. J Rheum Dis. 2023 Jul 1;30(3):151-169. doi: 10.4078/jrd.2023.0025. J Rheum Dis. 2023. PMID: 37476674 Free PMC article. Review.
Korean treatment recommendations for patients with axial spondyloarthritis.
Seo MR, Yeo J, Park JW, Lee YA, Lee JH, Kang EH, Ji SM, Kwon SR, Kim SK, Kim TJ, Kim TH, Kim HW, Park MC, Shin K, Lee SH, Lee EY, Cha HS, Shim SC, Yoon Y, Lee SH, Lim JH, Baek HJ; Korean Society of Spondyloarthritis Research. Seo MR, et al. Among authors: park mc. Korean J Intern Med. 2023 Sep;38(5):620-640. doi: 10.3904/kjim.2023.194. Epub 2023 Jul 24. Korean J Intern Med. 2023. PMID: 37482652 Free PMC article.
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.
Deodhar A, van der Heijde D, Gensler LS, Kim TH, Maksymowych WP, Østergaard M, Poddubnyy D, Marzo-Ortega H, Bessette L, Tomita T, Leung A, Hojnik M, Gallo G, Li X, Adams D, Carlier H, Sieper J; COAST-X Study Group. Deodhar A, et al. Lancet. 2020 Jan 4;395(10217):53-64. doi: 10.1016/S0140-6736(19)32971-X. Epub 2019 Dec 5. Lancet. 2020. PMID: 31813637 Clinical Trial.
Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Cho SK, Kim H, Song YJ, Kim HW, Nam E, Lee SS, Lee HS, Park SH, Lee YA, Park MC, Chang SH, Kim HA, Kwok SK, Kim HR, Kim HS, Yoon BY, Uhm WS, Kim YG, Kim JH, Lee J, Choi J, Sung YK. Cho SK, et al. Among authors: park mc. Korean J Intern Med. 2023 Jul;38(4):546-556. doi: 10.3904/kjim.2022.369. Epub 2023 Jun 20. Korean J Intern Med. 2023. PMID: 37334513 Free PMC article.
Statins reduce relapse rate in Takayasu arteritis.
Kwon OC, Oh JS, Park MC, Hong S, Lee CK, Yoo B, Kim YG. Kwon OC, et al. Among authors: park mc. Int J Cardiol. 2019 Jul 15;287:111-115. doi: 10.1016/j.ijcard.2019.02.046. Epub 2019 Feb 20. Int J Cardiol. 2019. PMID: 30824260
87 results